From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nature reviews. Drug discovery

• Publication date

  2016-01-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrd.2015.21PMID 26794270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood–brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody

  2015cited by this paper
• The blood-brain barrier in neuroimmunology: Tales of separation and assimilation.

  2015cited by this paper
• Role of P-Glycoprotein in Refractoriness of Seizures to Antiepileptic Drugs in Lennox-Gastaut Syndrome

  2015cited by this paper
• Myristic acid conjugation of [D-Leu-4]-OB3, a biologically active leptin-related synthetic peptide amide, significantly improves its pharmacokinetic profile and efficacy.

  2014cited by this paper
• Smuggling Drugs into the Brain: An Overview of Ligands Targeting Transcytosis for Drug Delivery across the Blood–Brain Barrier

  2014cited by this paper
• Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain.

  2014cited by this paper
• Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers.

  2014cited by this paper
• Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle.

  2014cited by this paper
• Recent progress in tight junction modulation for improving bioavailability

  2014cited by this paper
• Central and Peripheral Administration of Antisense Oligonucleotide Targeting Amyloid-β Protein Precursor Improves Learning and Memory and Reduces Neuroinflammatory Cytokines in Tg2576 (AβPPswe) Mice

  2014cited by this paper
• Pathogen-inspired drug delivery to the central nervous system

  2014cited by this paper
• Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: a pilot study.

  2014cited by this paper
• Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease.

  2014cited by this paper
• High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by pharmacological inhibition of mitochondrial carbonic anhydrases: Implications for cerebral microvascular disease in diabetes.

  2013cited by this paper
• Transporters of the blood-brain and blood-CSF interfaces in development and in the adult.

  2013cited by this paper
• Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in Alzheimer's Disease

  2013cited by this paper
• Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

  2013cited by this paper
• Pericyte loss influences Alzheimer-like neurodegeneration in mice

  2013cited by this paper
• Pharmacological Inhibition of Mitochondrial Carbonic Anhydrases Protects Mouse Cerebral Pericytes from High Glucose-Induced Oxidative Stress and Apoptosis

  2013cited by this paper
• Immune activation of human brain microvascular endothelial cells inhibits HIV replication in macrophages.

  2013cited by this paper
• Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.

  2013cited by this paper
• Brain delivery of proteins via their fatty acid and block copolymer modifications

  2013cited by this paper
• Brain pericytes increase the lipopolysaccharide-enhanced transcytosis of HIV-1 free virus across the in vitro blood–brain barrier: evidence for cytokine-mediated pericyte-endothelial cell crosstalk

  2013cited by this paper
• Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown.

  2013cited by this paper
• Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice.

  2012cited by this paper
• Peripheral Administration of Antisense Oligonucleotides Targeting the Amyloid-β Protein Precursor Reverses AβPP and LRP-1 Overexpression in the Aged SAMP8 Mouse Brain

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• Human Immunodeficiency Virus-1 Uses the Mannose-6-Phosphate Receptor to Cross the Blood-Brain Barrier

  2012cited by this paper
• A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β

  2012cited by this paper
• The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment.

  2012cited by this paper
• Soluble Interleukin-6 Receptor Induces Motor Stereotypies and Co-Localizes with Gp130 in Regions Linked to Cortico-Striato-Thalamo-Cortical Circuits

  2012cited by this paper
• Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy.

  2012cited by this paper
• Lipopolysaccharide-induced fever depends on prostaglandin E2 production specifically in brain endothelial cells.

  2012cited by this paper
• Pegylated granulocyte colony-stimulating factor conveys long-term neuroprotection and improves functional outcome in a model of Parkinson's disease.

  2012cited by this paper
• Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

  2012cited by this paper
• Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood–brain barrier

  2012cited by this paper
• Cell-mediated drug delivery

  2011cited by this paper
• Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia

  2011cited by this paper
• 1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier

  2011cited by this paper
• O1‐07‐04: Blood‐brain barrier p‐glycoprotein function in Alzheimer's disease

  2011cited by this paper
• A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo

  2011cited by this paper
• Targeting the neurovascular unit for treatment of neurological disorders.

  2011cited by this paper
• Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease

  2011cited by this paper
• Brain insulin controls adipose tissue lipolysis and lipogenesis.

  2011cited by this paper
• Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF

  2011cited by this paper
• Impairments in Brain-to-Blood Transport of Amyloid-β and Reabsorption of Cerebrospinal Fluid in an Animal Model of Alzheimer's Disease are Reversed by Antisense Directed Against Amyloid-β Protein Precursor

  2011cited by this paper
• Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target

  2011cited by this paper
• Minimal penetration of lipopolysaccharide across the murine blood-brain barrier.

  2010cited by this paper
• Central Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer's Disease-Related Animal Models Despite Reported Blood-Brain Barrier Disruption

  2010cited by this paper
• Pericytes are required for blood–brain barrier integrity during embryogenesis

  2010cited by this paper
• ABC efflux transporters in brain vasculature of Alzheimer's subjects.

  2010cited by this paper
• A Pharmacologically Active Monoclonal Antibody against the Human Melanocortin-4 Receptor: Effectiveness After Peripheral and Central Administration

  2010cited by this paper
• COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.

  2010cited by this paper
• Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

  2010cited by this paper
• Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain

  2010cited by this paper
• Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease

  2010cited by this paper
• Isolation of Peptide Transport System-6 from Brain Endothelial Cells: Therapeutic Effects with Antisense Inhibition in Alzheimer and Stroke Models

  2009cited by this paper
• Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity.

  2009cited by this paper
• eNOS gene deletion restores blood‐brain barrier integrity and attenuates neurodegeneration in the thiamine‐deficient mouse brain

  2009cited by this paper
• Targeting the CNS to treat type 2 diabetes

  2009cited by this paper
• Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis1

  2009cited by this paper
• Targeting carbonic anhydrase to treat diabetic retinopathy: emerging evidences and encouraging results.

  2009cited by this paper
• Testing the Neurovascular Hypothesis of Alzheimer's Disease: LRP-1 Antisense Reduces Blood-brain Barrier Clearance, Increases Brain Levels of Amyloid-β Protein, and Impairs Cognition

  2009cited by this paper
• Investigation of the Influence of FcRn on the Distribution of IgG to the Brain

  2009cited by this paper
• Cessation of Blood-to-Brain Influx of Interleukin-15 during Development of EAE

  2009cited by this paper
• Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier.

  2008cited by this paper
• Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.

  2008cited by this paper
• The effects of natalizumab on the innate and adaptive immune system in the central nervous system.

  2008cited by this paper
• Neuroinflammation Activates Mdr1b Efflux Transport Through NFκB: Promoter Analysis in BBB Endothelia

  2008cited by this paper
• Chemically modified β-glucuronidase crosses blood–brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII

  2008cited by this paper
• Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT).

  2008cited by this paper
• Strategies to advance translational research into brain barriers.

  2008cited by this paper
• Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults

  2008cited by this paper
• CNS Delivery Via Adsorptive Transcytosis

  2008cited by this paper
• Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier.

  2008cited by this paper
• Tumor Necrosis Factor α and Endothelin-1 Increase P-Glycoprotein Expression and Transport Activity at the Blood-Brain Barrier

  2007cited by this paper
• Cyclooxygenase Inhibition Limits Blood-Brain Barrier Disruption following Intracerebral Injection of Tumor Necrosis Factor-α in the Rat

  2007cited by this paper
• Interactions between the "cognitive" and "metabolic" brain in the control of food intake.

  2007cited by this paper
• Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.

  2007cited by this paper
• Epinephrine enhances lysosomal enzyme delivery across the blood–brain barrier by up-regulation of the mannose 6-phosphate receptor

  2007cited by this paper
• TNF Activates P-Glycoprotein in Cerebral Microvascular Endothelial Cells

  2007cited by this paper
• The blood–brain-barrier in multiple sclerosis: Functional roles and therapeutic targeting

  2007cited by this paper
• Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier.

  2007cited by this paper
• Evidence that N-acetylcysteine inhibits TNF-alpha-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen- and stress-activated protein kinase.

  2006cited by this paper
• Stroke upregulates TNFalpha transport across the blood-brain barrier.

  2006cited by this paper
• Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide.

  2006cited by this paper
• RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

  2006cited by this paper
• Brain Uptake of Nonsteroidal Anti-Inflammatory Drugs: Ibuprofen, Flurbiprofen, and Indomethacin

  2006cited by this paper
• Estradiol Reduces Activity of the Blood–Brain Barrier Na–K–Cl Cotransporter and Decreases Edema Formation in Permanent Middle Cerebral Artery Occlusion

  2006cited by this paper
• Stroke upregulates TNFα transport across the blood–brain barrier

  2006cited by this paper
• Receptor-mediated transport of LIF across blood-spinal cord barrier is upregulated after spinal cord injury.

  2006cited by this paper
• Astrocyte–endothelial interactions at the blood–brain barrier

  2006cited by this paper
• Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats.

  2006cited by this paper
• Glycosylated neuropeptides: A new vista for neuropsychopharmacology?

  2005cited by this paper
• Chickenpox

  2005cited by this paper
• Pericytes and the Pathogenesis of Diabetic Retinopathy

  2005cited by this paper
• Branched-chain amino acids and brain function.

  2005cited by this paper
• The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

  2005cited by this paper
• Neurovascular mechanisms of Alzheimer's neurodegeneration.

  2005cited by this paper
• Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells.

  2005cited by this paper

• CRISPR–Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges

  2026cites this paper
• Neuroinflammation and blood-brain barrier disruption in Japanese encephalitis virus infection: mechanisms, therapeutic targets, and intervention strategies.

  2026cites this paper
• Zinc‐Based Nanocomposites for Alzheimer's Therapy: Restoring Metal Homeostasis and Inhibiting Neurotoxic Protein Aggregation

  2026cites this paper
• Potential of ethyl acetate and acetone extracts from Montrichardia linifera leaves: Chemical characterization, in vitro study, molecular docking ad ADME-TOX.

  2026cites this paper
• Exploring Green-Synthesized Silver Nanoparticles in Neurodegeneration: a Systematic Review of Cholinesterase Enzyme Interactions

  2026cites this paper
• Multifunctional Nanoparticles in Traumatic Brain Injury: From Targeted Imaging and Diagnosis to Innovative Therapeutics

  2026cites this paper
• Toxoplasma gondii as a drug for anti-tumor immunotherapy: mechanisms, challenges, and perspectives

  2026cites this paper
• Methylprednisolone in the pathogenesis of inflammatory lesions of the central nervous system associated with microorganisms of the genus Acinetobacter (A. radioresistens, A. baumannii) in dogs

  2026cites this paper
• Fucoidan Extracted from Fucus vesiculosus Ameliorates Colitis-Associated Neuroinflammation and Anxiety-like Behavior in Adult C57BL/6 Mice

  2026cites this paper
• Engineering nanobodies for drug delivery systems in Alzheimer's disease.

  2026cites this paper
• Deep3BPP: Identification of Blood–Brain Barrier Penetrating Peptides Using Word Embedding Feature Extraction Method and CNN-LSTM

  2026cites this paper
• Strategies for blood-brain barrier rejuvenation and repair.

  2026cites this paper
• Renewing the theoretical framework of intensity correlation analysis to evaluate blood-brain barrier permeability with spectral fluorescence microscopy in mice

  2026cites this paper
• Metabolic GLUT1 Priming with Disulfide-Stabilized Micelles Enables Noninvasive mRNA Delivery across the Blood-Brain Barrier.

  2026cites this paper
• Pharmacological modulation of the blood-brain barrier: Mechanisms, therapeutic strategies, and emerging technologies.

  2026cites this paper
• Intranasal delivery of peptide-modified quercetin liposomes suppresses neuroinflammation.

  2026cites this paper
• Self-Assembled Rg3/Naringenin Nanoparticles for Targeted Brain Delivery: A Promising Therapeutic Approach for Early Alzheimer’s Disease

  2026cites this paper
• Cross-kingdom miRNA delivery by Panax notoginseng-derived extracellular-like nanoparticles vesicles restores neuronal function after ischemic injury.

  2026cites this paper
• Lymphoid Organ Architecture and Hematopoiesis Disruption in Spinal Muscular Atrophy: Therapeutic Rescue by SMN Restoration

  2026cites this paper
• PTX-loaded, polysorbate 80-functionalized brain-targeting pullulan nanoparticles for drug delivery

  2026cites this paper
• Neuro-lymphaphotonics opens new horizons of the future technologies for the therapy of brain diseases

  2026cites this paper
• Targeted Drug Delivery in Animal Models of Demyelination: The Role of Plant-Based Nanoparticles with a Focus on Multiple Sclerosis

  2026cites this paper
• Ligand content-dependent exocytosis governs the blood-brain barrier transcytosis of nanocarriers.

  2026cites this paper
• How gut microbiota contribute to neuropsychiatric disorders: evidence from neuroimaging studies

  2026cites this paper
• Characterization of a custom 3D-printed microfluidic aerosolizer for enhanced nose-to-brain delivery of nanoemulsion.

  2025cites this paper
• Navigating the Central Nervous System (CNS): A Pharmacokinetic Approach to the Treatment of CNS Tumors, Glioblastoma Multiforme (GBM), in Particular

  2025cites this paper
• Beyond the blood-brain barrier: the fate of transcytosed therapeutics.

  2025cites this paper
• Manifold Embedding of Quantum Information as Molecule Representation to Predict Blood-Brain Barrier Permeability by Deep Learning.

  2025cites this paper
• Blood–Brain Barrier Penetration of Novel 4-Trifluoromethyl-Coumarin Hybrids with Antibacterial Properties as Potential Brain Therapeutics in the Context of Spatially Diverse Healthcare Systems

  2025cites this paper
• Association between periodontal disease and Alzheimer's disease: a scoping review

  2025cites this paper
• Peripheral immune cell-specific genes in Parkinson’s disease uncovered by multi-omics with therapeutic implications

  2025influential citation
• Network toxicology and molecular docking to investigate the association of perfluorooctane sulfonate and pulmonary arterial hypertension via adverse outcome pathways.

  2025cites this paper
• Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context

  2025cites this paper
• THE IMPACT OF GUT MICROBIOTA ON THE PATHOPHYSIOLOGY AND MANIFESTATION OF ADHD

  2025cites this paper
• Microglial Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapies

  2025cites this paper
• Vesicle-guided mitochondria: A new perspective for brain mitochondrial transplantation.

  2025cites this paper
• Pathogenic breaches: how viruses compromise blood-tissue barriers

  2025cites this paper
• Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention

  2025cites this paper
• The Central Anatomical Question: Treatment of Lymphoma Within Border-Zone Anatomical Sites Adjacent to the Central Nervous System

  2025cites this paper
• A comprehensive review on natural polysaccharides based in situ gels for nasal drug delivery.

  2025cites this paper
• Lab-in-the-loop machine learning for brain-targeting delivery system design

  2025cites this paper
• PET imaging for non-invasive monitoring of 89Zr-Talidox delivery to the brain following focused ultrasound-mediated blood-brain barrier opening

  2025cites this paper
• ENDOTHELIAL GLYCOCALYX DEGRADATION IN CEREBRAL EDEMA: PROMISING OPPORTUNITIES FOR INTENSIVE CARE

  2025cites this paper
• Polymeric 3D-Printed Microneedle Arrays for Non-Transdermal Drug Delivery and Diagnostics

  2025cites this paper
• Crossing Barriers: Advancements in Macromolecular Therapeutics for Neurodegenerative Diseases and Strategies to Overcome the Blood-Brain Barrier.

  2025cites this paper
• Disruption of the cerebrospinal fluid–plasma protein balance in cognitive impairment and aging

  2025cites this paper
• Feasibility of targeted alpha therapy for Alzheimer’s disease using 211At-labeled agent targeting amyloid-β aggregates

  2025cites this paper
• Natural polysaccharides in colloidal drug delivery systems for brain glioma therapy: Mechanisms and advancements.

  2025cites this paper
• Strategies for delivering drugs across the blood-brain barrier for the treatment of neurodegenerative diseases

  2025cites this paper
• Overcoming the Blood–Brain Barrier: Advanced Strategies in Targeted Drug Delivery for Neurodegenerative Diseases

  2025cites this paper
• Molecular Aspects of Geriatric Pharmacotherapy

  2025cites this paper
• Discovery of Functionalized 1H-Benzo[d]imidazoles That Confer Protective Effects in a Phenotypic CLN3 Disease Patient-Derived iPSC Model.

  2025cites this paper
• As48, a First-in-Class Dual-Function TREM2 Modulator: Receptor Activation and Shedding Inhibition

  2025cites this paper
• Unveiling anaphylatoxins: Pioneering cancer therapies through complement system insights.

  2025cites this paper
• Unlocking ferulic acid for neurological diseases and tailoring of nanoformulations to advance its brain delivery.

  2025cites this paper
• SPP1+ macrophages polarized by lactate confer the progression of hypoxic adaptive tumor cells in brain.

  2025cites this paper
• A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriers

  2025cites this paper
• Drug Delivery Systems for Overcoming Physical Barriers in Cancer Therapy.

  2025cites this paper
• Nanobiotechnology‐Based Approaches for Targeted Glioma Therapy

  2025cites this paper
• Harnessing nanotechnology for improved drug delivery across the blood-brain barrier and enhanced neural repair.

  2025cites this paper
• Bacterial infection hypothesis-based therapies for Alzheimer's disease

  2025cites this paper
• Pathological complete response to conversion therapy for lung adenocarcinoma with brain metastasis: a case report

  2025cites this paper
• Recent Advances in the Therapeutic Effects and Molecular Mechanisms of Baicalin

  2025cites this paper
• Multiscale analysis and optimal glioma therapeutic candidate discovery using the CANDO platform

  2025cites this paper
• Chalcogenapyrylium-engineered D-π-A probe for enhanced optoacoustic imaging of amyloid-β plaques

  2025cites this paper
• Extracellular vesicles as a promising tool in neuropsychiatric pharmacotherapy application and monitoring.

  2025cites this paper
• Gut microbiota and their influence in brain cancer milieu

  2025cites this paper
• Models and mechanisms of post-stroke dementia and cognitive impairment

  2025cites this paper
• Phytochemicals encouraging neurotrophic pathways: brain-derived neurotrophic factors as molecular targets in depression

  2025cites this paper
• Polymeric Nanocarriers Functionalized with Peptides for Improved Glioblastoma Targeting and Blood-Brain Barrier Permeability.

  2025cites this paper
• Diagnostics of brain tumor in the early stage: current status and future perspectives.

  2025cites this paper
• Promoting Drug Delivery to the Brain by Modulating the Transcytosis Process across the Blood-Brain Barrier.

  2025cites this paper
• Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions

  2025cites this paper
• Targeted miRNA Delivery in Epilepsy: Mechanisms, Advances, and Therapeutic Potential

  2025cites this paper
• Biomimetic Nanoparticles Enhance Recovery of Movement Disorders in Parkinson's Disease by Improving Microglial Mitochondrial Homeostasis and Suppressing Neuroinflammation.

  2025cites this paper
• Application of in silico methods to predict the acute toxicity of bicyclic organophosphorus compounds as potential chemical weapon

  2025influential citation
• Nanotherapeutic strategies exploiting biological traits of cancer stem cells

  2025cites this paper
• Exploring neuropharmacokinetics: mechanisms, models, and clinical implications

  2025cites this paper
• Brain Targeting Bacterial Extracellular Vesicles Enhance Ischemic Stroke Therapy via Efficient ROS Elimination and Suppression of Immune Infiltration.

  2025cites this paper
• Cell membrane-coated nanoparticles: a biomimetic strategy for effective treatment of ischemic stroke

  2025cites this paper
• An update on the clinical trial research of immunotherapy for glioblastoma

  2025cites this paper
• Capillary‐Driven 3D Open Fluidic Networks for Versatile Continuous Flow Manipulation

  2025cites this paper
• Expanding horizons in theragnostics: from oncology to multidisciplinary applications

  2025cites this paper
• Advanced Strategies for Ultrasound Control and Applications in Sonogenetics and Gas Vesicle-Based Technologies: A Review

  2025cites this paper
• Developing intranasally administered electro-responsive nanodrugs for rapid epilepsy treatment

  2025cites this paper
• Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting.

  2025cites this paper
• Targeted suppression of glioma by ultralow-dose x-ray-induced photodynamic therapy and gold-based nanoclusters in preclinical models.

  2025cites this paper
• Biosynthesized nanoparticles of Tibetan medicine mercuric sulfide preparation to promote endocytosis and realize drug crossing through blood brain barrier

  2025cites this paper
• Living Cell Materials for Advanced Biomedical Applications in Disease Diagnosis, Treatment, and Prevention

  2025cites this paper
• Framework Nucleic Acid Nanomaterials for Central Nervous System Therapies: Design for Barrier Penetration, Targeted Delivery, Cellular Uptake, and Endosomal Escape.

  2025cites this paper
• Smart micro/nanorobots for drug delivery in the brain

  2025cites this paper
• Deep Learning for Blood-Brain Barrier Permeability Prediction

  2025cites this paper
• Nasal Nanotherapeutics for Central Nervous System Disorders: Bridging the Translational Gap in Central Nervous System Drug Delivery.

  2025cites this paper
• Harnessing Organoid Platforms for Nanoparticle Drug Development

  2025cites this paper
• Organoid-driven nanomedicine platform development.

  2025cites this paper
• Molecular Windows into the Brain: Advances in BBB-Penetrable NIR Fluorescent Imaging Probes.

  2025cites this paper
• Nanodiamond Mediated Delivery of Pyridinium Oxime Antidotes to Central Nervous System for Potential Treatment of Exposure to Nerve Agents.

  2025cites this paper
• Material considerations for delivering therapeutics across the blood–brain barrier

  2025cites this paper
• A Novel Glycosylated Ferulic Acid Conjugate: Synthesis, Antioxidative Neuroprotection Activities In Vitro, and Alleviation of Cerebral Ischemia–Reperfusion Injury (CIRI) In Vivo

  2025cites this paper
• Harnessing the Potential of Exosomes in Therapeutic Interventions for Brain Disorders

  2025cites this paper